
Myovant: Endometriosis Setback Hints At Issues Around Pfizer Partnership (NYSE:MYOV)
PeopleImages/E+ via Getty Images Investment Thesis Myovant Sciences (NYSE:MYOV) was the largest biotech IPO of 2016, raising $218m at a listing price of $15, which valued the company at ~$875m. More than five years later, […]